NDC 80425-0004-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0004
- Requested NDC
- 80425-0004-01
- Package NDCs from labels
- 80425-0004-1, 80425-0004-2, 80425-0004-3, 80425-0004-4, 80425-0004-5, 80425-0004-6, 80425-0004-7, 80425-0004-01
- Manufacturer
- ADVANCED RX PHARMACY OF TENNESSEE, LLC
- Effective date
- 2024-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - ADVANCED RX PHARMACY OF TENNESSEE, LLC | ADVANCED RX PHARMACY OF TENNESSEE, LLC | 2024-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0004-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 5 | |
| 80425-0004-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 5 | |
| 80425-0004-3 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 5 | |
| 80425-0004-4 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 5 | |
| 80425-0004-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 5 | |
| 80425-0004-6 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 5 | |
| 80425-0004-7 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0004 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 7 package rows | 20240314_af49507d-254f-296d-e053-2a95a90ad263.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0004-1 | EA - Each | 80425-0004 | 568b0d95-e053-4078-9588-aae633aac1c8 | 1 | 2023-03-13 |
| 80425-0004-2 | EA - Each | 80425-0004 | 08cd35d1-2cad-40a7-91fb-fdb8337d9e65 | 1 | 2023-03-13 |
| 80425-0004-3 | EA - Each | 80425-0004 | fbaf8b0f-38f5-4531-9f5b-26ccf9d8e766 | 1 | 2024-06-10 |
| 80425-0004-4 | EA - Each | 80425-0004 | 49b4d903-13ce-40d3-89cf-31cd97d711e7 | 1 | 2024-04-05 |
| 80425-0004-5 | EA - Each | 80425-0004 | 1020912e-44d0-4ba7-bbbc-b3ce215a7748 | 1 | 2024-04-05 |
| 80425-0004-6 | EA - Each | 80425-0004 | 88fa8483-8c3b-4c86-bbfe-68a6da75564f | 1 | 2024-04-05 |
| 80425-0004-7 | EA - Each | 80425-0004 | 9246bd25-019c-471d-a5b0-e435a401b8e4 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f4ced8c7-a276-4a44-a60c-f8d1689a2bdf | 2024-07-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6e5f9616-ddf2-19c4-e053-2991aa0a372a | 2024-07-18 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ada33464-b416-9ac6-e053-2a95a90af787 | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ade02343-3e4b-b1f1-e053-2995a90ac5fe | 2024-07-17 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | a33280d4-7caf-f74b-e053-2a95a90a90c3 | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc | 945552cb-90e4-41fb-afe2-8ee8785e94da | 2024-07-17 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 3fcb3f88-9dfc-444d-952a-1d1967720525 | 2024-06-28 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 4eb58a7e-1c92-4be3-b702-e522e0fbf425 | 2024-06-21 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 20f8cc57-231c-4d36-a209-ff9e5735d65c | 2024-06-20 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 90a76d24-e5a9-9000-e053-2a95a90ae8af | 2024-06-19 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6ac71dc8-7f86-60c5-e053-2a91aa0a2a7e | 2024-06-10 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6be20569-df34-04d9-e053-2991aa0a94fd | 2024-06-10 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 728c5212-dbd8-8df5-e053-2a91aa0a9579 | 2024-06-10 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 681c235f-6dee-1401-e053-2991aa0addc0 | 2024-06-07 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 73920373-b45d-45d6-b183-d962467dde36 | 2024-05-24 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | fc426d0d-9774-4189-8d83-89aa85d926bb | 2024-05-22 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 712a6789-7aab-4114-ae92-d1c7686c6b96 | 2024-05-16 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 5b7666f3-4014-45ce-8387-3298d9fe6d25 | 2024-05-07 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 141bd050-5dfc-68fa-e063-6394a90a6d86 | 2024-03-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | ADVANCED RX PHARMACY OF TENNESSEE, LLC | af49507d-254f-296d-e053-2a95a90ad263 | 2024-03-12 | Warnings, Adverse reactions | ANDA065253 80425-0004-5 80425-0004-4 80425-0004-2 80425-0004-1 80425-0004-3 80425-0004-6 80425-0004-7 80425-0004 80425000401 309114 137a5de3-ab83-e2ab-e063-6294a90a6209 af49507d-254f-296d-e053-2a95a90ad263 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.